Literature DB >> 7238644

Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.

J G Eernisse, A Brand.   

Abstract

From January 1972 to July 1974, 28 patients with bone marrow depression due to aplastic anemia or cytostatic treatment, were transfused with packed cells and platelet concentrates, both containing 10-20% of the amount of leukocytes present in whole blood. Of these patients, 26 (93%) became refractory to random platelets. Since July 1974, 68 patients have been given red cells filtered through cotton-wool, a procedure which removes over 97% of the leukocytes, and leukocyte-poor platelet suspensions obtained by an additional centrifugation step. Of this latter group, 16 patients (24%) became refractory. Fifty-two recipients were non-refractory to random platelet transfusions after an exposure time of at least 6 weeks and maximally 32 weeks. A possible explanation is that platelets are less immunogenic than leukocytes; on the other hand platelets may not be immunogenic at all with regard to induction of HLA antibodies, and the occurrence of the immunization is purely the result of the contamination with leukocytes in the red cell and platelet preparations.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7238644

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  14 in total

1.  New directions for the hospital blood transfusion service.

Authors:  G H Growe; M Sinclair
Journal:  CMAJ       Date:  1988-02-01       Impact factor: 8.262

2.  The impact of the HLA system in clinical hematology.

Authors:  J J van Rood
Journal:  Blut       Date:  1989-09

Review 3.  The use of blood components in patients with malignancy.

Authors:  S Murphy
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

4.  Survival in vivo of platelets stored for 48 hours in the buffycoat at 4 degrees C compared to platelet rich plasma stored at 22 degrees C.

Authors:  R N Pietersz; J A Loos; H W Reesink
Journal:  Blut       Date:  1987-04

5.  Autologous platelet transfusion in alloimmunized patients with acute leukemia.

Authors:  I Funke; M Wiesneth; K Koerner; M Cardoso; E Seifried; B Kubanek; H Heimpel
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

6.  Serum inhibitors in aplastic anaemia.

Authors:  C N Winkel; H M Goselink; W F Veenhof; F H Claas; J Jansen
Journal:  Blut       Date:  1982-04

Review 7.  Platelet therapy.

Authors:  V P Choudhry
Journal:  Indian J Pediatr       Date:  2002-09       Impact factor: 1.967

8.  Detection and Identification of Platelet-Associated Alloantibodies by a Solid-Phase Modified Antigen Capture Elisa (MACE) Technique and Its Correlation to Platelet Refractoriness in Multi platelet Concentrate Transfused Patients.

Authors:  R S Sarkar; J Philip; Neelesh Jain
Journal:  Indian J Hematol Blood Transfus       Date:  2014-03-29       Impact factor: 0.900

9.  Analysis of Plasma Products for Cellular Contaminants: Comparing Standard Preparation Methods.

Authors:  Richard R Rieske; Matthew E Kutcher; Jon P Audia; Kristen T Carter; Yann-Leei Lee; Yong B Tan; Mark N Gillespie; Gina C Capley; Danielle M Tatum; Alison A Smith; Juan C Duchesne; Jon D Simmons
Journal:  J Am Coll Surg       Date:  2020-04       Impact factor: 6.113

Review 10.  Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation.

Authors:  E L Snyder
Journal:  Yale J Biol Med       Date:  1990 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.